Condensed Consolidated Statement of Changes in Stockholders' Deficiency (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Series B Preferred Stock [Member]
Beginning Balance
Beginning Balance, shares	100	100
Common stock issued upon exercise of warrants
Net loss
Other comprehensive loss
Ending Balance
Ending Balance, shares	100	100
Common Stock [Member]
Beginning Balance	$ 384,615	$ 370,962
Beginning Balance, shares	384,614,528	370,961,451
Common stock issued upon exercise of warrants	$ 100	$ 7,927
Common stock issued upon exercise of warrants, shares	100,000	7,926,739
Net loss
Other comprehensive loss
Ending Balance	$ 384,715	$ 378,889
Ending Balance, shares	384,714,528	378,888,190
Additional Paid-In Capital [Member]
Beginning Balance	$ 209,092,187	$ 208,351,431
Common stock issued upon exercise of warrants	5,230	414,568
Net loss
Other comprehensive loss
Ending Balance	209,097,417	208,765,999
Accumulated Other Comprehensive Loss [Member]
Beginning Balance
Common stock issued upon exercise of warrants
Net loss
Other comprehensive loss	(22,363)
Ending Balance	(22,363)
Accumulated Deficit [Member]
Beginning Balance	(226,894,291)	(218,741,236)
Common stock issued upon exercise of warrants
Net loss	(1,369,830)	(2,899,612)
Other comprehensive loss
Ending Balance	(228,264,121)	(221,640,848)
Beginning Balance	(17,417,489)	(10,018,843)
Common stock issued upon exercise of warrants	5,330	422,495
Net loss	(1,369,830)	(2,899,612)
Other comprehensive loss	(22,363)
Ending Balance	$ (18,804,352)	$ (12,495,960)